rs886043606
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PVS1PM2PP3PP5_Very_Strong
The NM_000214.3(JAG1):c.439C>T(p.Gln147*) variant causes a stop gained, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000214.3 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Publications
- Alagille syndrome due to a JAG1 point mutationInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- Charcot-Marie-Tooth disease, axonal, Type 2HHInheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- tetralogy of fallotInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| JAG1 | NM_000214.3 | c.439C>T | p.Gln147* | stop_gained, splice_region_variant | Exon 3 of 26 | ENST00000254958.10 | NP_000205.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| JAG1 | ENST00000254958.10 | c.439C>T | p.Gln147* | stop_gained, splice_region_variant | Exon 3 of 26 | 1 | NM_000214.3 | ENSP00000254958.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Alagille syndrome due to a JAG1 point mutation Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 287254). This premature translational stop signal has been observed in individual(s) with Alagille syndrome (PMID: 16575836, 19948535, 26076142). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln147*) in the JAG1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in JAG1 are known to be pathogenic (PMID: 11180599). -
This mutation caused stop gain in JAG1 gene and expected to result a pathogenic loss of function variant. This is previously reported by Warthen 2006 and Liting Li 2015 . -
not provided Pathogenic:1
- -
JAG1-related disorder Pathogenic:1
The JAG1 c.439C>T variant is predicted to result in premature protein termination (p.Gln147*). This variant has been reported to be pathogenic for Alagille syndrome (Warthen et al. 2006. PubMed ID: 16575836). To our knowledge, this variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in JAG1 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at